Medications in Life Stages

Dear Colleagues,

Optimising medication use for different life-stages remains challenging. In most disease states, communicable and non-communicable, medication individualisation and therapy adherence remain major determinants of patient outcomes. Evidence suggests there is still a great deal of work required to achieve best practice in all life stages. The recent validation of practical bedside tools, usable by a range of professionals including pharmacists, for the diagnosis of delirium superimposed on dementia, provides a major opportunity in care of the elderly. Since delirium can mostly be effectively managed, this, coupled with the recent increased understanding of the role of anticholinergic burden opens major opportunities in reducing medication caused cognitively-impairment in the elders. There have been major developments in managing parenteral therapy in paediatric and neonatal intensive care, finding new ways to avoid precipitation risk within the infusion tubing. These are just two examples. In this Special Issue, we are seeking your contributions to share knowledge on innovative ways for tailoring medication use for the different life stages; neonates, infants, children, adolescents, adults, pregnancy and breastfeeding, elders and in the syndrome of frailty. All contributions on this subject will be considered; clinical trials, observational studies, reviews, topic case studies, monitoring tools and educational interventions. We hope this will provide an interesting and valuable reference source for better practice.

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• Clinical pharmacy
• Chronic diseases management
• Primary care
• Pediatrics
• Neonatology
• Gerontology
• Pregnancy
• Mental health
• Hospital at home
• Special populations care